Integrated acidity and the pathophysiology of gastroesophageal reflux disease

American Journal of Gastroenterology

Volumn 96, Issue 5, 2001, Pages 1363-1370

  Gardner, Jerry D ^a   Rodriguez Stanley, Sheila ^b   Robinson, Malcolm ^b  

^a Science for Organizations Inc   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON;

ACIDITY; ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION FUNCTION; DUODENOSCOPY; ESOPHAGITIS; ESOPHAGOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STOMACH ACID SECRETION;

EID: 0035005777     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02353-X     Document Type: Article

References (31)

1. Jamieson J.R., Stein H.J., DeMeester T.R., et al. Ambulatory 24-H esophageal pH monitoring Normal values, optimal thresholds, specificity, sensitivity, and reproducibility . Am J Gastroenterol. 87:1992;1102-1111.
2. Quigley E.M.M. 24-H pH monitoring for gastroesophageal reflux disease Standard but not yet gold? Am J Gastroenterol. 87:1992;1071-1075.
3. Bell N.J.V., Burget D., Howden C.W., et al. Appropriate acid suppression for the management of gastroesophageal reflux disease. Digestion. 51:(suppl 1):1992;59-67.
4. Hunt R.H. The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 9:(suppl 1):1995;3-7.
5. Hatlebakk J.G., Berstad A. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease. Clin Pharmacokinet. 31:1996;386-406.
6. Dent J. Gastro-oesophageal reflux disease. Digestion. 59:1998;433-445.
7. Orlando R.C. Why is the high grade inhibition of gastric acid secretion afforded by proton pump inhibitors often required for healing of reflux esophagitis? An epithelial perspective. Am J Gastroenterol. 91:1996;1692-1696.
8. Robinson M., Maton P.N., Rodriguez S., et al. Effects of oral rabeprazole on oesophageal and gastric pH in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 11:1997;973-980.
9. Hetzel D.J., Dent J., Reed W.D., et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology. 95:1988;903-912.
10. Moore E.W., Scarlata R.W. The determination of gastric acidity by the glass electrode. Gastroenterology. 49:1965;178-188.
11. Makhlouf G.M., Blum A.L., Moore E.W., et al. Undissociated acidity of human gastric juice. Gastroenterology. 58:1970;345-351.
12. DeMeester T.R., Johnson L.F., Joseph G.J., et al. Patterns of gastroesophageal reflux in health and disease. Ann Surg. 84:1976;459-470.
13. DeCastecker J.S., Blackwell J.N., Pryde A., et al. Daytime gastro-oesophageal reflux is important in oesophagitis. Gut. 28:1987;519-526.
14. Robertson D., Aldersley M., Shepherd H., et al. Patterns of acid reflux in complicated oesophagitis. Gut. 28:1987;1484-1488.
15. Gillen P., Keeling P., Byrne P.J., et al. Barrett's oesophagus pH profile. Br J Surg. 74:1987;774-776.
16. Fiorucci S., Santucci L., Farroni F., et al. Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus. Am J Gastroenterol. 84:1989;1263-1267.
17. Hirschowitz B. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology. 101:1991;1149-1158.
18. Hirschowitz B. Gastric secretion of acid and pepsin in patients with esophageal stricture and appropriate controls. Dig Dis Sci. 41:1996;2115-2122.
19. Hirschowitz B. Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls. Dig Dis Sci. 41:1996;1384-1391.
20. Collen M.J., Lewis J.H., Benjamin S.B., et al. Gastric acid hypersecretion in gastroesophageal reflux disease. Gastroenterology. 98:1990;654-661.
21. Collen M.J., Johnson D.A. Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus. Dig Dis Sci. 37:1992;570-576.
22. Johansson K-.E., Ask P., Boeryd B., et al. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol. 21:1986;837-847.
23. Bremner R.M., Crookes P.F., DeMeester T.R., et al. Concentration of refluxed acid and esophageal mucosal injury. Am J Surg. 164:1992;522-527.
24. Williams M.P., Sercombe J., Hamilton M.I., et al. A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects. Aliment Pharmacol Ther. 12:1998;1079-1089.
25. Fordtran J.S., Walsh J.H. Gastric acid secretion rate and buffer content of the stomach after eating. J Clin Invest. 52:1973;645-657.
26. Feldman M., Richardson C.T. Total 24-hour gastric acid secretion in patients with duodenal ulcer. Gastroenterology. 90:1986;540-544.
27. Makhlouf G.M., McManus J.P.A., Card W.I., et al. A quantitative statement of the two-component hypothesis of gastric secretion. Gastroenterology. 51:1966;149-171.
28. Dammann H.G., Fuchs W., Richter G., et al. Lansoprazole versus omeprazole Influence on meal-stimulated gastric acid secretion . Aliment Pharmacol Ther. 11:1997;359-364.
29. Peghini P.L., Katz P.O., Bracy N.A., et al. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol. 93:1998;763-767.
30. Katz P.O., Anderson C., Khoury R., et al. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors. Aliment Pharmacol Ther. 12:1998;1231-1234.
31. Hatlebakk J.G., Katz P.O., Kuo B., et al. Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily. Aliment Pharmacol Ther. 11:1998;1235-1240.